Cover Image

Two‐stage randomized clinical trials with a right‐censored endpoint: Comparison of frequentist and Bayesian adaptive designs

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Luana Boumendil, Sylvie Chevret, Vincent Lévy, Lucie Biard
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Statistics in Medicine
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Doubly adaptive biased coin design to improve Bayesian clinical trials with time‐to‐event endpoints
by: Wenhao Cao, et al.
Published: (2024)

Use of win time for ordered composite endpoints in clinical trials
by: James F. Troendle, et al.
Published: (2024)

Design of randomized clinical trials with a binary endpoint: Conditional versus unconditional analyses of a two‐by‐two table
by: Edward L. Korn, et al.
Published: (2024)

Dynamic path analysis for exploring treatment effect mediation processes in clinical trials with time‐to‐event endpoints
by: Matthias Kormaksson, et al.
Published: (2024)

Assurance methods for designing a clinical trial with a delayed treatment effect
by: James A. Salsbury, et al.
Published: (2024)

A sequential, multiple assignment, randomized trial design with a tailoring function
by: Holly Hartman, et al.
Published: (2024)

Correction to “Propensity score weighting for covariate adjustment in randomized clinical trials”
by: Shuxi Zeng, et al.
Published: (2024)

Group sequential designs for clinical trials when the maximum sample size is uncertain
by: Amin Yarahmadi, et al.
Published: (2024)

A two‐stage group‐sequential design for delayed treatment responses with the possibility of trial restart
by: Stephen Schüürhuis, et al.
Published: (2024)

Comparison of methods that combine multiple randomized trials to estimate heterogeneous treatment effects
by: Carly Lupton Brantner, et al.
Published: (2024)

Two‐stage stratified designs with survival outcomes and adjustment for misclassification in predictive biomarkers
by: Yanping Chen, et al.
Published: (2024)

A unified Bayesian framework for bias adjustment in multiple comparisons from clinical trials
by: Yu Du, et al.
Published: (2024)

Dual‐agent dose‐finding in Phase I clinical trial—An extension of rapid enrollment design
by: Yunfei Wang
Published: (2024)

A class of computational methods to reduce selection bias when designing Phase 3 clinical trials
by: Tianyu Zhan
Published: (2024)

Understanding an impact of patient enrollment pattern on predictability of central (unstratified) randomization in a multi‐center clinical trial
by: Johannes Krisam, et al.
Published: (2024)

Fractional accumulative calibration‐free odds (f‐aCFO) design for delayed toxicity in phase I clinical trials
by: Jialu Fang, et al.
Published: (2024)

Evaluating analytic models for individually randomized group treatment trials with complex clustering in nested and crossed designs
by: Jonathan C. Moyer, et al.
Published: (2024)

Distributional imputation for the analysis of censored recurrent events
by: Sarah R. Fairfax, et al.
Published: (2024)

Assessing heterogeneity in surrogacy using censored data
by: Layla Parast, et al.
Published: (2024)

Are the tests overpowered or underpowered? A unified solution to correctly specify type I errors in design of clinical trials for two sample proportions
by: Peiran Liu, et al.
Published: (2024)

Correction to “Using principal stratification in analysis of clinical trials”
by: Ilya Lipkovich, et al.
Published: (2024)

τ$$ \tau $$‐Inflated beta regression model for censored recurrent events
by: Yizhuo Wang, et al.
Published: (2024)

Variance‐components tests for genetic association with multiple interval‐censored outcomes
by: Jaihee Choi, et al.
Published: (2024)

Determining sample size in a personalized randomized controlled (PRACTical) trial
by: Rebecca M. Turner, et al.
Published: (2024)

Improved mortality analysis in early‐phase dose‐ranging clinical trials for emergency medical diseases using Bayesian time‐to‐event models with active comparators
by: Xiaosong Shi, et al.
Published: (2024)

Adding experimental treatment arms to multi‐arm multi‐stage platform trials in progress
by: Thomas Burnett, et al.
Published: (2024)

Confidence distributions for treatment effects in clinical trials: Posteriors without priors
by: Ian C. Marschner
Published: (2024)

Erratum to “Joint modeling for censored predictors due to detection limits with applications to metabolites data”
Published: (2024)

Confidence intervals for odds ratio from multistage randomized phase II trials
by: Shiwei Cao, et al.
Published: (2024)

Multiply robust generalized estimating equations for cluster randomized trials with missing outcomes
by: Dustin J. Rabideau, et al.
Published: (2024)

A Comparison of Two Methods for Adaptive Multi‐Arm Two‐Stage Design
by: Cyrus Mehta, et al.
Published: (2025)

An information‐theoretic approach for the assessment of a continuous outcome as a surrogate for a binary true endpoint based on causal inference: Application to vaccine evaluation
by: Ariel Alonso Abad, et al.
Published: (2024)

A Note on “A Comparison of Two Methods for Adaptive Multi‐Arm Two‐Stage Design”
by: Silke Jörgens, et al.
Published: (2026)

A hybrid approach to sample size re‐estimation in cluster randomized trials with continuous outcomes
by: Samuel K Sarkodie, et al.
Published: (2024)

Design and sample size determination for multiple‐dose randomized phase II trials for dose optimization
by: Peng Yang, et al.
Published: (2024)

REDOMA: Bayesian random‐effects dose‐optimization meta‐analysis using spike‐and‐slab priors
by: Cheng‐Han Yang, et al.
Published: (2024)

A multi‐arm multi‐stage platform design that allows preplanned addition of arms while still controlling the family‐wise error
by: Peter Greenstreet, et al.
Published: (2024)

Utilizing local likelihood in regression discontinuity design: Investigating the impact of antiretroviral therapy eligibility on retention in clinical HIV care in South Africa
by: Jaehyun Seo, et al.
Published: (2024)

A Bayesian Two‐Step Multiple Imputation Approach Based on Mixed Models for Missing EMA Data
by: Yiheng Wei, et al.
Published: (2025)

Beyond the two‐trials rule
by: Leonhard Held
Published: (2024)